Danaher Corp EV/EBITDA
Data as of August 04, 2026
EV/EBITDA
27.30
Enterprise Value
$159.28B
EBITDA (TTM)
$5.84B
Sector
Life Sciences Tools & Services
How It's Calculated
27.30 = $159.28B ÷ $5.84B
What This Means
Danaher Corp's EV/EBITDA of 27.3 is elevated, which can reflect growth expectations, scarce assets, or cyclical EBITDA.
About Danaher Corp
Danaher Corp (DHR) operates in the Life Sciences Tools & Services sector, specifically in Life Sciences Tools & Services. With a market capitalization of about $137.07B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $197.50, within a 52-week range of $160.93 to $242.80 (-18.7% from the high, +22.7% from the low). Beta of 0.78 indicates relatively lower volatility versus the market.
Trailing profit margin is about 16.0%, signaling a solid profit margin for its industry.
Understanding This Metric
EV/EBITDA is widely used when comparing companies with different debt loads because enterprise value includes net debt while EBITDA approximates operating cash earnings power. For Danaher Corp, the ratio should be read with growth, capex needs, and cycle position in Life Sciences Tools & Services. Pair EV/EBITDA with free cash flow yield and net debt metrics before drawing conclusions — especially when EBITDA is depressed or boosted by one-time items.
Using This Number in Practice
Near 27.30x EV/EBITDA, Danaher Corp (DHR) carries an elevated EV/EBITDA multiple that may embed growth expectations or scarcity within its peer set. Enterprise value of about $159.28B and EBITDA near $5.84B form the ratio — adjust for one-time items before treating the headline multiple as comparable.
Credit and LBO workflows often sort names on EV/EBITDA before drilling into free cash flow and maintenance capex. Pair this view with the EV/EBITDA calculator and the DHR metrics hub for related valuation pages.
Sector Comparison
Among Life Sciences Tools & Services names on our S&P 100 coverage, Danaher Corp's EV/EBITDA of 27.30 can be compared with peers such as TMO (26.89). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Life Sciences Tools & Services stocks.
Key Takeaways
- DHR is grouped in the Life Sciences Tools & Services sector for peer comparisons.
- Recent beta of 0.78 suggests lower-than-market price sensitivity.
- Trailing profit margin of 16.0% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for DHR.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Other DHR Metrics
Frequently Asked Questions
What is DHR's EV/EBITDA?
EV/EBITDA compares enterprise value to operating earnings before interest, taxes, depreciation, and amortization. Danaher Corp's ratio is about 27.30 — common for comparing leveraged companies in Life Sciences Tools & Services.
Is 27.30 high or low vs peers?
Among Life Sciences Tools & Services peers (e.g. TMO (26.89)), DHR's 27.30 should be read with growth, capex, and debt levels.
When is EV/EBITDA misleading?
EBITDA ignores capex, working capital, and stock-based comp; negative or tiny EBITDA makes the ratio meaningless. Cross-check with free cash flow and net debt.
Calculate the ev/ebitda for any stock with our free calculator.
Open EV/EBITDA Calculator →